Search

Your search keyword '"Ilan Raymond"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Ilan Raymond" Remove constraint Author: "Ilan Raymond"
39 results on '"Ilan Raymond"'

Search Results

1. The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

2. Beneficial and harmful effects of sacubitril/valsartan in patients with heart failure: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

3. Databasen for Atrieflimren i Danmark – Resumé af årsrapport 2021

4. Prognostic Value of Coronary CT Angiography in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

5. The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 x 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (met-HeFT)☆

6. Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

7. Long‐term L‐Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐blind, cross‐over, placebo‐controlled intervention study

8. Plasma calprotectin levels reflect disease severity in patients with chronic heart failure

9. Cardiovascular Events in Thyroid Disease: A Population Based, Prospective Study

10. Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population

11. Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure

12. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population

13. Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes

14. Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice

15. N-Terminal Pro-Brain Natriuretic Peptide in Arterial Hypertension: A Valuable Prognostic Marker of Cardiovascular Events

16. Biochemical Cardiac Risk Markers in the General Population, Hypertension and Coronary Artery Disease

17. The prognosis of impaired left ventricular systolic function and heart failure in a middle-aged and elderly population in an urban population segment of Copenhagen

18. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

19. The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background Population

20. Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)

21. α-Defensins and outcome in patients with chronic heart failure

22. Plasma YKL-40 levels are elevated in patients with chronic heart failure

23. Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians

24. Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population

25. N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism

26. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

27. Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly

28. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

29. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen

30. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population

31. Does isolated diastolic dysfunction explain dyspnea in a population with preserved left ventricular systolic function and no signs of lung disease?

32. 609 Abnormal ECG is a significant prognostic marker in subjects with preserved left ventricular function including those with dyspnea— Five years of follow up in a middle-aged and elderly population

33. 385 Value of left ventricular filling parameters to predict mortality in a sample of subjects with preserved systolic function from the general population

34. N-T pro-BNP and the diagnosis of heart failure: A pooled analysis of three European epidemiological studies

35. The Reply

37. N-Terminal-Pro-B-type Natriuretic Peptide in Acute Hyperthyroidism.

38. 1161-178 N-terminal pro-brain natriuretic peptide can identify high and low risk patients with hypertension and preserved left ventricular systolic function in the general population

39. 1049-118 N-terminal pro-brain natriuretic peptide and urinary albumin excretion is independent predictors of all cause mortality in the general population

Catalog

Books, media, physical & digital resources